3,4-dihydroxyphenylacetic acid has been researched along with sr 48692 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brun, P; Fournier, M; Le Fur, G; Mons, G; Rodier, D; SoubriƩ, P; Souilhac, J; Steinberg, R; Terranova, JP | 1 |
Cheung, S; Hentschel, K; Lookingland, KJ; Moore, KE | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and sr 48692
Article | Year |
---|---|
SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dopamine; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Synaptic Transmission; Tegmentum Mesencephali | 1994 |
Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Binding, Competitive; Dopamine; Dopamine Antagonists; Female; Haloperidol; Male; Median Eminence; Neurons; Neurotensin; Prolactin; Pyrazoles; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurotensin; Sex Factors | 1998 |